Podcast
MSL Talk: Tom Caravela, Chris Castin
All about Job Offers and what to be aware of
Summary
E66 • Aug 17, 2021 • 41 mins
In this episode, Tom Caravela welcomes Anthony Greco to discuss job offer negotiations. Anthony shares insights on clear communication and understanding legal aspects during compensation discussions. They explore the risks of over-negotiation and emphasize early talks on compensation. The conversation covers negotiable elements like sign-on bonuses and long-term incentives. Anthony offers guidance on navigating non-compete and non-solicitation agreements, providing legal advice and identifying red flags in employment agreements. The episode concludes with reflections on the candidate's experience during the hiring process.
Anthony Greco, Talent Acquisition Lead at BMS discusses what you need to know about job offers and how to properly handle them.
Anthony shares….
👉 What should be included in an Offer Letter
👉 How to best negotiate a Job Offer
👉 Is it true to “Never Accept the First Offer”?
👉 How do sign on bonuses work and when can you expect one
👉 What does “At Will Employment” mean
👉 How to handle a “non compete” and why it differs from a “non solicitation”
job offer negotiations, compensation discussions, employment agreements, non-compete agreements, sign-on bonuses
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Chris Castin
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
Article
J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo & R. Álvarez-Alegret